Biocon Biologics to Acquire Viatris' Biosimilars Assets for up...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BENGALURU, India, Feb. 28, 2022 /PRNewswire-AsiaNet/ -- - Immediately Accretive Combination Creates a Unique Global, Vertically Integrated Biosimilars LeaderBiocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its part...
Authors: LATEST ASIANET NEWS RELEASES